During the past decade, The First University Clinic of Tbilisi State Medical University conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First University Clinic of Tbilisi State Medical University" #1 sponsor was "Biocad" with 2 trials, followed by "BrainsGate" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Alvotech Swiss AG" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First University Clinic of Tbilisi State Medical University" #1 collaborator was "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Phytomed AB" with 1 trials as a collaborator, "Tbilisi State Medical University" with 1 trials as a collaborator and "The University of New South Wales" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The First University Clinic of Tbilisi State Medical University" are "Crohn's Disease" (2 trials), "Ischemic Stroke" (2 trials), "Cancer" (1 trials), "Cervical Cancer" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "The First University Clinic of Tbilisi State Medical University" in a lesser frequency.

Most popular intervention types in "The First University Clinic of Tbilisi State Medical University" are "Drug" (9 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BCD-100" (2 trials), "PF-06651600" (2 trials), "PF-06700841" (2 trials) and "Active Sphenopalatine Ganglion (SPG) Stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "The First University Clinic of Tbilisi State Medical University" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The First University Clinic of Tbilisi State Medical University". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The First University Clinic of Tbilisi State Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First University Clinic of Tbilisi State Medical University, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".